Did you know that of the 3.5 million Australians living with arthritis, almost 960,000 also live with a mental health condition?
The umbrella term ‘spondyloarthritis’ refers to the types of autoimmune conditions that affect both the joints and the entheses (the points where ligaments and tendons attach to bones).
In May, CreakyJoints Australia was delighted to once again attend the Australian Rheumatology Association Annual Scientific Meeting, this year held in Melbourne.
In May, CreakyJoints Australia’s national coordinator, Naomi Creek, attended a 2018/19 Health Budget briefing in Canberra with Federal Health Minister Greg Hunt.
Trexject® (a range of pre-filled methotrexate syringes) will be listed under the Pharmaceutical Benefits Scheme (PBS) from 1 April 2018 for those with severe rheumatoid arthritis or psoriasis.
According to the Victorian Model of Care for Osteoarthritis of the Hip and Knee, the prevalence of OA in Victoria alone will increase by 42% 0 by 2030.
In August 2017, the Council of Australian Governments (COAG) approved Australia’s new National Digital Health Strategy (the Strategy) entitled, ‘Safe, seamless and secure: evolving health and care to meet the needs of modern Australia‘.
The vaccine-style treatment, known as DEN-181, uses immunotherapy to treat the cause of this debilitating autoimmune disease.
Recently, the Australian Healthcare and Hospitals Association produced the report, Rheumatology nurses: adding value to arthritis care which was commissioned by Arthritis Australia.
With new codeine regulations on the horizon, we need to rethink pain management strategies to include drug-free alternatives.